Serum levels of specialised pro-resolving molecule pathways are greatly increased in SARS-CoV-2 patients and correlate with markers of the adaptive immune response

James Turnbull, Rakesh Jha, Catherine A. Ortori, Eleanor Lunt, Patrick J. Tighe, William L. Irving, Sameer A. Gohir, Dong-Hyun Kim, Ana M. Valdes, Alexander W. Tarr, David A. Barrett, Victoria Chapman
doi: https://doi.org/10.1101/2021.12.07.21267409

Article usage

Article usage: December 2021 to April 2025

AbstractFullPdf
Dec 20216222145
Jan 202287541
Feb 20223029
Mar 20222822
Apr 20222239
May 20222849
Jun 20222506
Jul 20222701
Aug 20221723
Sep 20223007
Oct 20222723
Nov 20222322
Dec 20222147
Jan 20231916
Feb 20232222
Mar 20232721
Apr 20232133
May 20231825
Jun 20231241
Jul 2023821
Aug 202315116
Sep 20231959
Oct 20231210
Nov 202317107
Dec 20231804
Jan 2024953
Feb 20241637
Mar 20241035
Apr 202411310
May 20241131
Jun 20241546
Jul 202411215
Aug 20242059
Sep 20241114
Oct 202432922
Nov 202424213
Dec 20242816
Jan 202519215
Feb 202512289
Mar 2025252213
Apr 20251469
Back to top
Posted December 11, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Serum levels of specialised pro-resolving molecule pathways are greatly increased in SARS-CoV-2 patients and correlate with markers of the adaptive immune response
James Turnbull, Rakesh Jha, Catherine A. Ortori, Eleanor Lunt, Patrick J. Tighe, William L. Irving, Sameer A. Gohir, Dong-Hyun Kim, Ana M. Valdes, Alexander W. Tarr, David A. Barrett, Victoria Chapman
medRxiv 2021.12.07.21267409; doi: https://doi.org/10.1101/2021.12.07.21267409
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area